Search is Powered by Google
HIV / AIDS News

Irish Government Launches Program To Provide Life Insurance To People With HIV, Hepatitis C Through Contaminated Blood Products

Main Category: HIV / AIDS
Also Included In: Liver Disease / Hepatitis;  Blood / Hematology;  Health Insurance / Medical Insurance
Article Date: 02 Oct 2007 - 12:00 PDT

email icon email to a friend   printer icon printer friendly   write icon view / write opinions   rate icon rate article
Current Article Ratings:

Patient / Public:not yet rated

Health Professional:not yet rated

Article Opinions: 0 posts

The Irish government on Thursday launched a program to provide life insurance, mortgage protection and travel insurance to people who contracted HIV or hepatitis C through contaminated blood products, Ireland's Evening Echo reports (Evening Echo, 9/27).

In the mid-1980s, about half of Ireland's 500 hemophiliacs contracted HIV or hepatitis C from the nation's blood supply. In April 2002, then Irish Health Minister Michael Martin and the Irish Hemophilia Society announced a $90 million deal to compensate hemophiliacs who were infected with HIV from state-provided contaminated blood products (Kaiser Daily HIV/AIDS Report, 4/15/02). According to the Evening Echo, about 3,300 people in Ireland have initiated claims against the government related to infections from contaminated blood products.

People who enroll in the new insurance plan -- which is expected to cost about 1.1 billion pounds, or about $2.2 billion -- will pay the average premium for an HIV-negative person of the same age and gender, and the government will cover additional costs. Applications for mortgage protection and life insurance will be subject to restrictions after 12 months, the Evening Echo reports (Evening Echo, 9/27).

Eleanor O'Mahony -- chair of Positive Action, a group that represents women who acquired HIV or hepatitis C though blood transfusions -- said that the insurer Eagle Star is offering the policies and encouraged other insurers to offer policies so that "competition could be stimulated" (O'Sullivan, Irish Examiner, 9/28). The program, which was first announced last year, is the first of its kind worldwide, the Evening Echo reports (Evening Echo, 9/27).

Comments
Positive Action said the program is "long-awaited" and added that the group's members have been unable to purchase homes because of their medical conditions. Health Minister Mary Harney said the program is an "important measure to provide further support" to people who acquired HIV or other infectious diseases through contaminated blood products. Harney added that the "inability of these people to buy life [insurance] or mortgage protection policies added further problems to the damage they had already suffered."

John Dwyer, who will administer the program, said it will have a "very positive impact on the lives of those" living with HIV or hepatitis C. "This in effect means that they and their families will now have greater security and peace of mind into the future," Dwyer added (Irish Examiner, 9/28).

Reprinted with kind permission from http://www.kaisernetwork.org. You can view the entire Kaiser Daily Health Policy Report, search the archives, or sign up for email delivery at http://www.kaisernetwork.org/dailyreports/healthpolicy. The Kaiser Daily Health Policy Report is published for kaisernetwork.org, a free service of The Henry J. Kaiser Family Foundation© 2005 Advisory Board Company and Kaiser Family Foundation. All rights reserved.




Customized Homepage Weekly Newsletters Daily News Alerts
Home About Us News Licensing Free Website Feeds Free Tools & Content Links Tell a Friend Accessibility Help / FAQ Article Submission Contact Us
Psychiatry Urology
Bipolar Diabetes Schizophrenia

add medical news today to your facebook

medical news gadget

Add to Google


developers
website gadget code
website news code
medical news rss feed links


MedReader RSS Reader

customize your homepage


These are the most read articles from this news category for the last 6 months:
Top Article Star
FDA To Recommend That Doctors Conduct Genetic Screening Before Prescribing Antiretroviral Abacavir To Reduce Allergic Reactions
25 Jul 2008
FDA on Thursday is expected to issue an advisory that urges physicians to conduct genetic testing before prescribing GlaxoSmithKline's antiretroviral drug abacavir to reduce allergic reactions in people taking the drug, the...


Talking with Your Doctor image Talking with Your Doctor

Talking with your doctor can sometimes be difficult. Good health care, however, depends on an open dialogue between patients and doctors...

Keeping a Personal Medical Record image Keeping a Personal Medical Record

Medical information is usually scattered in many different places. To receive the best possible health care, people are encouraged to gather information in one place and create a personal medical record...

View more videos...